A Study of an Automated Insulin Delivery System in Adult Participants With Type 1 Diabetes Mellitus (T1D)
Status:
Completed
Trial end date:
2019-01-28
Target enrollment:
Participant gender:
Summary
The Automated Insulin Delivery (AID) System is an investigational insulin delivery device
being developed for use for participants with diabetes. The purpose of this study is to
assess the safety of the AID system and to test whether the AID System functions as designed.
The study will last about 3 months with up to 6 days of inpatient time.